A letter from 24 eminent physicians, researchers, ethicists and medical school professors objects strenuously to a Canadian advertising campaign that the group says promotes the benefits of a testosterone replacement, which could have dangerous side effects.
Primary reporters were Frédéric Zalac for CBC, Serena Tinari for RSI and Sandra Bartlett for NPR.
The Public Health Agency of Canada is looking to make public the drug company affiliations — and therefore any potential conflict of interest — of its expert advisers, CBC News has learned.
UBC report finds B.C. paying too much for generic prescription drugs
By Tiffany Crawford and Tracy Sherlock, Vancouver Sun May 19, 2011
British Columbians could have saved more than $150 million last year on generic prescription drugs if the province had adopted the same pricing model as Ontario, University of B.C. researchers say in a new report.
Statement on WHO governance and the Management of Conflicts of Interest and the Future of Financing for WHO
WHO and other public health institutions have complex relations with commercial entities that supply health care products and services. In some cases the commercial entities are subject to or in need of regulation, in order to protect consumers and promote the public interest. Public health institutions are also often engaged in buying goods and services, or providing financial assistance for such purchases.
ENG
FRA
ESP
